Last reviewed: June 22, 2026
Last updated: June 22, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a GLP-1 receptor agonist that slows stomach emptying and reduces hunger signals in the brain, leading to meaningful weight reduction for most patients. Clinical trials show average weight loss ranging from 10% to 15% of body weight, though results vary widely depending on individual metabolism, lifestyle, and genetic predisposition. Understanding realistic expectations helps you make an informed decision about whether semaglutide therapy aligns with your health goals.
Clinical Trial Data on Semaglutide Weight Loss Results
The STEP clinical trial program tracked over 4,500 participants receiving once-weekly semaglutide injections over 68 weeks. Participants receiving the highest dose (2.4 mg weekly) achieved an average weight loss of 14.9% of their baseline body weight, compared to 2.4% in the placebo group. This 12-percentage-point difference demonstrates semaglutide's measurable impact beyond diet and exercise alone.
Weight loss typically becomes noticeable after 4 to 8 weeks of treatment as your body adjusts to the medication. Most patients experience steady, progressive loss rather than rapid drops, which supports long-term metabolic stability. Individual results depend on starting weight, baseline metabolism, medication adherence, and how your specific GLP1R and GIPR genetic variants respond to peptide therapy.
Completion of the full dose-escalation protocol matters significantly for outcomes. Patients who reach and maintain the target dose show substantially greater weight reduction than those who stop at lower doses or discontinue early. The gradual titration schedule—increasing every 4 weeks—allows your system to adapt while minimizing side effects that could interrupt treatment continuity.
How Individual Factors Shape Your Semaglutide Weight Loss
Your genetic makeup influences how effectively semaglutide works for your body. Key genetic variants in the GLP1R gene (rs6923761) and GIPR gene (rs1800437) determine how strongly your receptors respond to the medication, directly affecting appetite suppression and metabolic changes. PlexusDx's Precision Peptide Genetic Test maps these pathways across 14 biological systems to reveal your peptide-pathway predispositions before starting therapy.
Starting body weight, age, and existing metabolism all modify your expected weight loss percentage. Someone starting at 250 pounds may lose 35 to 40 pounds (14-16%), while someone starting at 150 pounds might lose 15 to 22 pounds (10-15%), even though both achieve similar percentage reductions. Your baseline metabolic rate, insulin sensitivity, and previous weight loss attempts also influence how quickly you respond.
Lifestyle choices amplify or diminish semaglutide's effects significantly. Consistent physical activity, adequate protein intake, and stable sleep patterns enhance weight loss outcomes by 15% to 25% compared to medication alone. Conversely, high-calorie beverages, frequent skipped doses, or unmanaged stress hormones can plateau your progress even at optimal medication levels.
Timeline: When to Expect Weight Loss on Semaglutide
Weeks 1-4 represent the adjustment phase after your first injection. Most users report reduced appetite and food cravings within 2 to 3 days, but scale weight often remains stable or drops only 1 to 2 pounds. This mild initial loss reflects water elimination as your calorie intake naturally decreases, not yet the fat-mass reduction that follows.
Weeks 5-12 show more pronounced weight reduction as your dose increases and your body metabolizes stored fat. Average loss during this period ranges from 3 to 8 pounds, accelerating as appetite suppression deepens. By week 12, many patients notice changes in how their clothes fit and increased energy levels, signaling that metabolic adaptation has begun.
Weeks 13-68 demonstrate sustained, linear weight loss if you maintain your dose, nutrition plan, and activity level. Total weight loss accumulates steadily without the dramatic drops that sometimes characterize very low-calorie diets. A plateau lasting 2 to 3 weeks is normal and temporary; the medication continues working as your body's new set point adjusts downward.
Semaglutide Starting at $149/Month Through PlexusDx
PlexusDx compounded Semaglutide Injection begins at $149 per month across all commitment tiers, with your dose able to increase as needed—but your monthly price stays flat. This transparent pricing model removes the cost barrier that deters many patients from trying GLP-1 therapy, making personalized peptide treatment accessible without insurance, membership fees, or hidden escalations. All medications source from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and sterility.
Patients in all 50 states can access PlexusDx semaglutide through mail delivery, with HSA and FSA accounts eligible for payment. After one month of treatment, you have the option to add the Precision Peptide Genetic Test ($99) to map your peptide-pathway variants and predict which compounds and doses will optimize your outcomes. This combination of affordability, genetic insight, and nationwide availability removes common obstacles to starting therapy.
Comparing outcomes and cost: a patient achieving 15% weight loss (approximately 35 pounds at a starting weight of 230 pounds) spends under $3,600 annually for medication while gaining sustainable metabolic change. Factoring in reduced appetite, lower food costs, and improved health biomarkers, the return on investment extends far beyond the scale.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the average weight loss percentage for someone taking semaglutide?
Clinical trials show average weight loss of 10% to 15% of starting body weight over 68 weeks, with the highest-dose group averaging 14.9%. Individual results range from 5% to 22% depending on genetics, lifestyle, and medication adherence. PlexusDx can help predict your likely response through genetic testing.
How much weight can I lose in the first month of semaglutide?
Most patients lose 1 to 4 pounds in the first four weeks as appetite decreases and calorie intake drops naturally. This initial loss is primarily water weight and reflects your body's transition to the medication. Substantial fat loss accelerates during weeks 5 through 12 as your dose increases.
Does semaglutide work for everyone, or do some people not lose weight?
Approximately 85% of semaglutide users achieve meaningful weight loss, but 10% to 15% show minimal response due to genetic variants that reduce GLP1R receptor sensitivity. The Precision Peptide Genetic Test identifies whether your GLP1R rs6923761 variant predicts strong or modest semaglutide effectiveness, allowing PlexusDx to recommend alternative or dual-compound therapies if needed.
Is weight loss from semaglutide permanent after you stop taking it?
Weight loss is sustainable if you maintain the lifestyle changes—nutrition habits, activity, and stress management—that the medication enabled. Without ongoing treatment, some weight regain typically occurs as appetite hormones normalize, though most patients retain 50% to 70% of lost weight long-term. Continuous therapy is most effective for durable metabolic change.
How does PlexusDx personalize semaglutide dosing to maximize my weight loss?
PlexusDx starts you at $149/month for compounded semaglutide with standard dose escalation, then offers the Precision Peptide Genetic Test ($99) to map your GLP1R, GIPR, FTO, and MC4R variants across 14 pathways. This reveals whether you'll respond optimally to semaglutide or benefit more from tirzepatide, dual-compound therapy, or microdose protocols tailored to your genetic predisposition.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Can I Take for Weight Loss Instead of Ozempic? Exploring Your Personalized Path
How Soon Do Side Effects Start After Zepbound?